Genitourinary Cancer

A phase III trial evaluating the efficacy of nivolumab (Opdivo) for the treatment of advanced renal cell carcinoma has been stopped early after the immunotherapy agent demonstrated a survival advantage over the comparator drug, everolimus (Afinitor), in the CheckMate-025 trial.

Clinicians and the public need to be aware that being positive for BRCA mutations has consequences for men and their families, too.

Although use of robotic surgery for prostate cancer has surpassed open surgical procedures, the impact of this approach on patient quality of life has not been well-studied.

When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians.

The addition of docetaxel to standard hormonal therapy significantly improved survival among men with newly diagnosed, hormone-naïve advanced prostate cancer.

Statin use before or after a diagnosis of lung cancer may be linked to a reduced risk of death from the disease, according to findings of a recent study which found that patients who used statins in the year before a lung cancer diagnosis had a statistically significant 12% reduction in lung cancer-specific deaths.

A new study has found that obesity is associated with an increased risk for prostate cancer in African American men, a risk that grows by nearly four times as an individual's body-mass index (BMI) increases.

Please enjoy this music while your party is reached … "Hello, Mr. Freeman,* this is Venteria Knight. I'm a nurse navigator with Northside Hospital, and we met at the prostate cancer screening last week."

A new study has found that older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system.

A new study has shown that men with a high fitness level in midlife are not only at a lower risk of developing lung and colorectal cancer, they're also at a lower risk of dying from cancer if they're diagnosed later in life.

A new study has found that African American patients with cancer feel and describe depression differently than their Caucasian counterparts.

The continuing contentious debate about screening for prostate cancer remains top of mind among the public and lay press, but, Leonard G. Gomella, MD, told attendees at the 8th International Prostate Cancer Congress, the decision to screen or not to screen boiled down to "using common sense, shared decision making, and choosing the right patients to screen."

Having a family history of prostate cancer among first-degree relatives may also increase a women's risk of developing breast cancer, according to a new study.

The risk of dying from prostate cancer increased fourfold when active surveillance was used to monitor men with intermediate-risk disease compared with low-risk prostate cancer patients, according to results of a new study, the first to examine long-term outcomes of patients with low- versus intermediate-risk prostate cancer who have been managed with this conservative approach to care.

This section provides you with brief background information about kidney cancer and some immediate resources that may be helpful.

The patient's daughter had not been at the initial consult and thus had only secondhand information from her father and mother.

For older men with prostate cancer, adding radiation to hormone therapy is both tolerable and effective in reducing the number of deaths.

Women Against Prostate Cancer provide tips to encourage men to be healthier and signs of prostate cancer to be aware of

The study, published in BJU International, has found that androgen deprivation therapy (ADT) was associated with a 3.3-times increased risk of heart-related deaths in men with congestive heart failure or prior heart attacks.

The Prostate Cancer Foundation (PCF) announced that the partnership with the Movember Foundation has resulted in 7 new Challenge Awards for 2014. In May, it was announced that PCF received over $8.4 million from the Movember Foundation, the leading global organization committed to changing the face of men's health.

The Bladder Cancer Advocacy Network has announced its fall series of webinars, featuring bladder cancer experts on a variety of topics. The webinars are relevant to people with bladder cancer, caregivers, family, and friends:

The Prostate Cancer Foundation (PCF) has awarded 27 new Young Investigator Award selected from 16 countries to advance new drug discovery, immunotherapy, nutritional sciences, and diagnostics for precision medicine.

New research on the risk-reducing benefits of aspirin shed more light on its mechanism of action as well as its potential benefit to reduce the risk of aggressive prostate cancer

Dr. Drew Pinsky's personal battle with prostate cancer inspires him to join forces with PCF

With the use of MRI imaging to restrict doses to erectile tissues, nearly half of men treated with external beam radiation therapy (EBRT) for prostate cancer were able to be sexually active without aids or medications 5 years later, and nearly 80% could be sexually active if such support was an option

A new study from Thomas Jefferson University suggests that observation may not be right for all patients with early stage prostate cancer.

The FDA has expanded the approval for the androgen receptor inhibitor enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive mCRPC.

New research suggests that men who aren't well educated about their prostate cancer have a much more difficult time making treatment decisions.

Men diagnosed with prostate cancer after being diagnosed with depression were less likely to undergo definitive treatment for their cancer and had worse overall survival

An expert panel and focus groups in Michigan created Guidelines for the Primary Care Management of Prostate Cancer Post-Treatment Sequelae in 2009 and published an update in July 2014.